Why immunoglobulin therapy deserves more attention
Immunoglobulin therapy has become increasingly important as hospitals manage patients with primary immunodeficiencies, autoimmune disorders, neurologic diseases, and other complex conditions requiring long-term infusion therapy. As more care migrates beyond the inpatient setting, organizations must ensure quality and consistency across care environments.
Nearly 40% of specialty pharmacies recently surveyed by the American Society of Health-System Pharmacists reported current use of specialist staffing models dedicated to specific disease states, reflecting the growing complexity of specialty pharmacy practice and the need for deeper clinical expertise.
At the same time, reimbursement pressures continue reshaping infusion services. Industry analysts estimate the infusion services market exceeds $150 billion, while hospitals continue evaluating how to move appropriate patients safely into lower-cost outpatient settings without compromising quality or continuity of care.
Launched in March 2026, the Accreditation Commission for Health Care's (ACHC) new Distinction in Immunoglobulin Therapy recognizes advanced clinical and operational excellence in the delivery of the treatment across sites of care, says Caroline Girardeau, PharmD, MBA, PMP, BCPS, PCAB and pharmacy services program director for the ACHC.
“Aligned with the Immunoglobulin National Society’s standards of practice, [the distinction] serves as a benchmark for best clinical practice, documentation, staff competencies, quality assurance, and patient outcomes,” she says.
Girardeau notes that the recognition builds upon existing ACHC accreditation for specialty pharmacies, infusion pharmacies, and ambulatory infusion clinics already providing immunoglobulin therapy.
"The distinction recognizes clinician certifications, institutes a mentorship model to elevate the clinical performance of the entire care team, and reviews evidence showing ongoing performance improvement," she says.
Editor's note: This article was excerpted from our Inside Accreditation & Quality newsletter.
